Trinity Delta are the healthcare and life sciences specialists

We are experienced analysts providing the highest quality services and insights to small/mid-cap healthcare and life sciences companies, and to investors. Our core focus is institutional quality issuer-paid research in the biotech, medtech, speciality pharma, and consumer health sectors.

Research for all post MiFID II

Under MiFID II, whether you are an asset manager or a private investor, you can receive Trinity Delta research.

Our research is paid for by our corporate clients and we do not carry out any execution business. We do and will continue to make it freely available to all investors via multiple platforms (Trinity Delta and MiFID II).

Our Services

lited-and-private-company Listed and private company

Specialist sector research

Listed and private company coverage

active-investor Active investor

Active investor interactions

Sharing exciting investment ideas

Institutional quality reports

Institutional quality reports

Focused on what matters

Comprehensive product suite

Broad product suite

Valued by generalists and specialists

Multi-platform, global

Global distribution

Targeting a wide audience

Fully MiFID II Compliant

Fully MiFID II Compliant

Research freely available to everyone

Our Team

Our Values

We pride ourselves for our integrity and professionalism. Our word is our bond.

Integrity key to all our actions


Key to all our actions

Expertise in life sciences and related


Setting high standards

our-clients-always-come-first Our clients always come first

Clients always come first

Supporting your objectives

Trusted advisors

Trusted advisors

Collaboration and mutual respect

Our Clients